Spire Healthcare Group (LON:SPI) Shares Down 17.8% – Time to Sell?

Shares of Spire Healthcare Group plc (LON:SPI) fell 17.8% on Thursday . The company traded as low as GBX 169 ($2.18) and last traded at GBX 184.60 ($2.38). 5,565,048 shares changed hands during mid-day trading, an increase of 727% from the average session volume of 672,747 shares. The stock had previously closed at GBX 224.50 ($2.89).

Spire Healthcare Group Price Performance

The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The company has a 50-day moving average price of GBX 229.09 and a 200-day moving average price of GBX 230.72. The firm has a market capitalization of £741.30 million, a P/E ratio of 26.27, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI) last announced its quarterly earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.11) EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, sell-side analysts predict that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.